Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3 | N/A | N/A | N/A | 0 |
| Other current assets | 27 | 0 | 0 | 0 | 1 |
| TOTAL | $30 | $N/A | $N/A | $N/A | $1 |
| Non-Current Assets | |||||
| PPE Net | 110 | N/A | N/A | N/A | 110 |
| Other Non-Current Assets | 210 | 0 | 0 | 0 | 450 |
| TOTAL | $320 | $N/A | $N/A | $N/A | $560 |
| Total Assets | $290 | $N/A | $N/A | $N/A | $510 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 980 | 0 | 0 | 0 | 1,270 |
| Accrued Expenses | 70 | N/A | N/A | N/A | 70 |
| Other current liabilities | 810 | N/A | N/A | N/A | 340 |
| TOTAL | $3,280 | $N/A | $N/A | $N/A | $2,520 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,280 | $N/A | $N/A | $N/A | $2,520 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 32,911 | N/A | N/A | N/A |
| Common Shares | 30 | N/A | N/A | N/A | 30 |
| Retained earnings | -25,760 | N/A | N/A | N/A | -22,680 |
| Other shareholders' equity | 10 | 0 | 0 | 0 | 0 |
| TOTAL | $-2,990 | $N/A | $N/A | $N/A | $-2,010 |
| Total Liabilities And Equity | $290 | $0 | $0 | $0 | $510 |